Expanding the clinical phenotypes of MT-ATP6 mutations

Ester López-Gallardo1, Sonia Emperador1, Abelardo Solano2

  • 1Departamento de Bioquímica, Biología Molecular y Celular, Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain, Centro de Investigaciones Biomédicas en red de Enfermedades Raras (CIBERER), Spain.

Insights

Screening the MT-ATP6 gene identified three new mutations in mitochondrial DNA disorders. This highlights the importance of MT-ATP6 gene sequencing, even in patients without typical oxidative phosphorylation dysfunction signs.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Mitochondrial DNA (mtDNA) mutations in the MT-ATP6 gene are common in striatal necrosis syndromes.
  • Patients often lack clear histochemical or biochemical signs of oxidative phosphorylation dysfunction.
  • This leads to MT-ATP6 not being routinely screened in many mitochondrial disorders.

Purpose of the Study:

  • To investigate the role of MT-ATP6 gene mutations in a broader range of mitochondrial DNA disorders.
  • To identify novel pathogenic mutations within the MT-ATP6 gene.
  • To correct the diagnostic bias against analyzing MT-ATP6 in atypical cases.

Main Methods:

  • Screening of the MT-ATP6 gene in a large cohort of patients with suspected mitochondrial DNA disorders.
  • Biochemical, molecular-genetics, and cybrid analyses were performed in selected cases.
  • Phenotypic correlation with identified mutations.

Main Results:

  • Three novel pathogenic MT-ATP6 gene mutations were identified.
  • Two mutations were found in patients with phenotypes not typically associated with MT-ATP6 mutations.
  • Confirmed the presence of mutations despite normal oxidative phosphorylation test results in some patients.

Conclusions:

  • Sequencing the MT-ATP6 gene is crucial for diagnosing striatal necrosis syndromes.
  • MT-ATP6 gene analysis should be extended to other mitochondrial pathologies, especially when respiratory chain analyses are normal.
  • This broadens the diagnostic scope for mitochondrial DNA disorders.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.9K
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
16.1K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
18.8K